SPC478

Retífanlímab

  • Status:
    Veitt
  • Application date:
    29.7.2024
  • Application published:
    15.8.2024
  • Grant published:
    15.12.2025
  • Max expiry date:
    23.4.2039
  • Medicine name:
    Zynyz
  • Medicine for children:
    No

Timeline

Today
29.7.2024Application
15.8.2024Publication
15.12.2025Registration
23.4.2039Expires

Marketing license

  • IS authorization number:
    EU/1/24/1800
  • Date:
    15.5.2024
  • Foreign authorization number:
    EU/1/24/1800
  • Date:
    19.4.2024

Owner

  • Name:
    MacroGenics, Inc.
  • Address:
    9704 Medical Center Drive, Rockville, MD 20850 US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 22.11.2025

Upload documents